132 related articles for article (PubMed ID: 29926009)
21. Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients.
Sato D; Suzuki Y; Kano T; Suzuki H; Matsuoka J; Yokoi H; Horikoshi S; Ikeda K; Tomino Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1090-7. PubMed ID: 21778277
[TBL] [Abstract][Full Text] [Related]
22. Successful therapy with tonsillectomy plus pulse therapy for the relapse of pediatric IgA nephropathy treated with multi-drugs combination therapy.
Sakai N; Kawasaki Y; Waragai T; Oikawa T; Kaneko M; Sato T; Suyama K; Hosoya M
Fukushima J Med Sci; 2016 Jun; 62(1):68-73. PubMed ID: 27210310
[TBL] [Abstract][Full Text] [Related]
23. Membranous nephropathy in a female patient with X-linked thrombocytopenia.
Okada M; Nagasawa M; Oshiba A; Kawaguchi H
Pediatr Nephrol; 2023 Aug; 38(8):2873-2876. PubMed ID: 36451038
[TBL] [Abstract][Full Text] [Related]
24. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
[TBL] [Abstract][Full Text] [Related]
25. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.
Murakoshi M; Gohda T; Sonoda Y; Suzuki H; Tomino Y; Horikoshi S; Suzuki Y
Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
Sato Y; Ishida H; Shimizu T; Tanabe K
Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
[TBL] [Abstract][Full Text] [Related]
27. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
[TBL] [Abstract][Full Text] [Related]
28. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
29. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S
Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
[TBL] [Abstract][Full Text] [Related]
30. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
31. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
32. Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy.
Iwatani H; Inoue T; Wada Y; Nagasawa Y; Yamamoto R; Iijima H; Takehara T; Imai E; Rakugi H; Isaka Y
Biochem Biophys Res Commun; 2012 Nov; 428(3):339-42. PubMed ID: 23098908
[TBL] [Abstract][Full Text] [Related]
33. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
Kawaguchi T; Ieiri N; Yamazaki S; Hayashino Y; Gillespie B; Miyazaki M; Taguma Y; Fukuhara S; Hotta O
Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779
[TBL] [Abstract][Full Text] [Related]
34. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
35. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation.
Chovancova Z; Kuman M; Vlkova M; Litzman J
Transpl Int; 2015 Aug; 28(8):1005-9. PubMed ID: 25864580
[TBL] [Abstract][Full Text] [Related]
36. Tonsillectomy for the treatment of tonsillitis-induced immunoglobulin A nephropathy.
Liess BD; Mytyk C; Calhoun KH; Whaley-Connell AT
Am J Otolaryngol; 2010; 31(6):485-8. PubMed ID: 20015804
[TBL] [Abstract][Full Text] [Related]
37. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy.
Xie Y; Chen X; Nishi S; Narita I; Gejyo F
Kidney Int; 2004 Apr; 65(4):1135-44. PubMed ID: 15086452
[TBL] [Abstract][Full Text] [Related]
38. Tonsillectomy and corticosteroid therapy with concomitant methylprednisolone pulse therapy for IgA nephropathy.
Suwabe T; Ubara Y; Sogawa Y; Higa Y; Nomura K; Nakanishi S; Hoshino J; Sawa N; Katori H; Takemoto F; Hara S; Ohashi K; Takaichi K
Contrib Nephrol; 2007; 157():99-103. PubMed ID: 17495444
[TBL] [Abstract][Full Text] [Related]
39. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.
Hotta O; Miyazaki M; Furuta T; Tomioka S; Chiba S; Horigome I; Abe K; Taguma Y
Am J Kidney Dis; 2001 Oct; 38(4):736-43. PubMed ID: 11576876
[TBL] [Abstract][Full Text] [Related]
40. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
Lin X; Ding J; Zhu L; Shi S; Jiang L; Zhao M; Zhang H
Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
